Skip to content

STEVENS PHARMA

Active
Public limited companyfounded 199035 yrs activeMechelsesteenweg 130, 1970 Wezembeek-Oppem, BelgiumKBO/BCE: BE 0442.284.960
Summary

STEVENS PHARMA has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €324,659 and a net result of €39,269. Equity remains stable across the filed fiscal years (±0.2% per year). Its solvency ranks better than 89% of 4473 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisWatch ReportCompare
STEVENS PHARMAActiveChecked score 97/100
Risk analysis ReportCompare

Overview

What they do
Retail sale of pharmaceutical products
NACE 47730Warehousing and support activities for transportation NACE 52310
#9 oldest company in Wezembeek-Oppem, Wholesale and retail trade sector1 site
How big
€406,503total assets 2025
Staff
1.3 FTE
Equity
€324,659
Profit
€39,269
Financially healthy?
97 Excellent Checked score 2025
Bankruptcy chance 12 m
0.1%
Who decides
Accounts 18 d early0 of 4 deeds read
Why 97- Sector Retail trade (NACE 47)+ Liquidity: current ratio 4.06, cash €113,297+ Equity €324,659 (79.9% of total assets)+ Founded in 1990Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Better than 78% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Strong
Solvency 100+12
equity 79.9% of total assets
Liquidity 79+4
short-term debt 20.1% · cash 27.9%
Profitability 81+6
return on assets 9.7%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.7% (39,869 companies)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%▲ +0.9% vs 11-2024 01-2025: 0.1%▼ -0.9% vs 12-2024 02-2025: 0.1%● 0.0% vs 01-2025 03-2025: 0.1%▼ -1.8% vs 02-2025 04-2025: 0.1%▼ -0.9% vs 03-2025 05-2025: 0.1%▼ -0.9% vs 04-2025 06-2025: 0.1%▼ -5.5% vs 05-2025 07-2025: 0.1%▲ +16.3% vs 06-2025highest value 08-2025: 0.1%▼ -27.3% vs 07-2025 09-2025: 0.1%● 0.0% vs 08-2025 10-2025: 0.1%● 0.0% vs 09-2025 11-2025: 0.1%● 0.0% vs 10-2025 12-2025: 0.1%● 0.0% vs 11-2025 01-2026: 0.1%● 0.0% vs 12-2025 02-2026: 0.1%● 0.0% vs 01-2026 03-2026: 0.1%▼ -1.1% vs 02-2026 04-2026: 0.1%● 0.0% vs 03-2026 05-2026: 0.1%▼ -1.1% vs 04-2026 06-2026: 0.1%▼ -4.7% vs 05-2026 07-2026: 0.1%▲ +3.7% vs 06-2026 08-2026: 0.1%▼ -41.2% vs 07-2026lowest value 09-2026: 0.1%● 0.0% vs 08-2026lowest value 10-2026: 0.1%● 0.0% vs 09-2026lowest value
  • Liquidity: current ratio 4.06, cash €113,297 lowers the probability
  • Equity €324,659 (79.9% of total assets) lowers the probability
  • Founded in 1990 lowers the probability for this profile
  • Sector Retail trade (NACE 47) raises the probability
Credit up to €30,000 at 30 days acceptable
Liquidity ample (current ratio 4.06 against 2.21 in 2024; short-term debt: 20.1% and cash: 27.9% of total assets), and 20.1% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 92%, liquidity 83%, profitability 73%, growth against the median 66%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610020317, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Liquidity: current ratio 4.06, cash €113,297
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Equity €324,659 (79.9% of total assets)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Founded in 1990
In the bankruptcy model this factor lowers the probability for this profile.
KBO
raises risk · Sector Retail trade (NACE 47)
In the bankruptcy model this factor raises the probability.
KBO
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €324,659
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
18 d early
2024
24 d early
2023
29 d late
2022
31 d late
2021
31 d late
2020
18 d late
2019
138 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 29 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 30 August (4 of the last 5 filed years within 48 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Highest result since 2018net €39,269 ▲65.5%
  3. Annual accounts filedfiscal year 2024 · abbreviated…

Key points

  • Positive: Among the best 12% on solvencysector median 35.9% · 4,473 companies 79.9% View
  • Positive: 8 profitable years in a rowprofit 2025: €39,269 8 years View
  • Active since 1990founded 17-10-1990 35 years View

By topic

Financials

Fiscal year
2025
Total assets
€406,503
Profit
€39,269
Solvency
79.9%
Total assets▼ 9.8%
Net result
20182025
Go to Financials

Timeline

Events
12
Since
2017
Next accounts
by 31-07-2027
  1. 13-07-2026Annual accounts filed
  2. 31-12-2025Highest result since 2018
  3. 07-07-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
17-10-1990
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure